AngioDynamics Inc (ANGO)

NASDAQ

Currency in USD

ANGO Pro Research

15.72

-0.35(-2.18%)

Real-time Data·15:01:29

Fair Value

Unlock Value

Day's Range

15.67

16.16

52 wk Range

8.94

16.29

ANGO Income Statement

Assess the AngioDynamics income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the ANGO net worth.

Period Ending:

2017

31/05

2018

31/05

2019

31/05

2020

31/05

2021

31/05

2022

31/05

2023

31/05

2024

31/05

2025

31/05

2026

31/05

Total Revenues

aa.aa

316.22

338.75

303.91

292.5

320.17

Total Revenues Growth

aa.aa

+8.66%

+7.13%

-10.28%

-3.76%

+9.46%

Cost Of Revenues

aa.aa

150.49

164.51

149.22

134.79

145.28

Gross Profit

aa.aa

165.73

174.25

154.7

157.71

174.89

Gross Profit Growth

aa.aa

+5.7%

+5.14%

-11.22%

+1.94%

+10.9%

Gross Profit Margin %

aa.aa

52.41%

51.44%

50.9%

53.92%

54.62%

Other Operating Expenses, Total

aa.aa

183.95

193.56

188.66

181.27

197.36

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+7.1%	+5.22%	-2.53%	-3.91%	+8.87%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	30.48	29.69	31.32	25.85	28.93
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	134.01	144.45	144.18	145.6	157.61
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	0.63	0.11	-0.49	0.14

Operating Income

aa.aa

-18.22

-19.31

-33.96

-23.57

-22.47

Operating Income Growth

aa.aa

-21.76%

-6.01%

-75.84%

+30.59%

+4.68%

EBIT Margin %

aa.aa

-5.76%

-5.7%

-11.17%

-8.06%

-7.02%

Net Interest Expenses

aa.aa

-0.69

-2.7

1.61

0.98

-0.3

Net Interest Expenses Growth

aa.aa

+20.09%

-292.73%

+159.73%

-39.41%

-130.57%

Interest Expense, Total

aa.aa

-0.69

-2.7

-0.3

Interest And Investment Income

aa.aa

1.61

0.98

Other Non Operating Expenses, Total

aa.aa

-0.79

-0.55

-0.82

4.94

3.93

EBT, Excl. Unusual Items

aa.aa

-19.7

-22.57

-33.16

-17.65

-18.84

Gain (Loss) On Sale Of Assets

aa.aa

54.5

Other Unusual Items, Total

aa.aa

-9.55

-15.86

-35.37

-0.99

-3.64

EBT, Incl. Unusual Items

aa.aa

-29.95

-54.44

-191.64

-34.03

-36.3

EBT, Incl. Unusual Items Growth

aa.aa

+16.93%

-81.77%

-252.04%

+82.24%

-6.66%

EBT, Incl. Unusual Items Margin

aa.aa

-9.47%

-16.07%

-63.06%

-11.63%

-11.34%

Income Tax Expense

aa.aa

-3.4

-2

-7.29

-0.04

0.44

Net Income to Company

aa.aa

-26.55

-52.44

-184.35

-33.99

-36.74

Minority Interest

aa.aa

Net Income

aa.aa

-26.55

-52.44

-184.35

-33.99

-36.74

Net Income Growth

aa.aa

+15.85%

-97.54%

-251.53%

+81.56%

-8.09%

Net Income Margin %

aa.aa

-8.4%

-15.48%

-60.66%

-11.62%

-11.48%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

-26.55

-52.44

-184.35

-33.99

-36.74

Basic EPS - Continuing Operations

aa.aa

-0.68

-1.33

-4.59

-0.83

-0.88

Basic EPS - Continuing Operations Growth

aa.aa

+17.29%

-95.19%

-245.4%

+81.86%

-6.34%

Diluted EPS - Continuing Operations

aa.aa

-0.68

-1.33

-4.59

-0.83

-0.88

Diluted EPS - Continuing Operations Growth

aa.aa

+17.29%

-95.44%

-245.11%

+81.87%

-6.34%

Basic Weighted Average Shares Outstanding

aa.aa

39.01

39.48

40.18

40.85

41.53

Diluted Weighted Average Shares Outstanding

aa.aa

39.01

39.48

40.18

40.85

41.53

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

11.13

11.56

-8.65

-1.17

0.19

EBITDA Growth

aa.aa

+1.62%

+3.86%

-174.77%

+86.48%

+116.08%

EBITDA Margin %

aa.aa

3.52%

3.41%

-2.84%

-0.4%

0.06%

EBIT

aa.aa

-18.22

-19.31

-33.96

-23.57

-22.47

* In Millions of USD (except for per share items)

FAQ

What was AngioDynamics’s revenue at year end?

At the end of the last reported fiscal year, AngioDynamics (ANGO) recorded total revenue of 320.17 million USD.

How much revenue did AngioDynamics report in the most recent quarter?

In its most recent quarterly earnings report, AngioDynamics posted revenue of 86.61 million USD.

What was AngioDynamics’s net income for the year?

For the full year, AngioDynamics reported net income of -36.74 million USD.

How much net income did AngioDynamics post in the last quarter?

In the most recent quarter, AngioDynamics (ANGO) posted net income of -11.41 million USD.

What was AngioDynamics’s gross profit for the year?

Gross profit for the year was reported at 174.89 million USD.

How much gross profit did AngioDynamics generate last quarter?

AngioDynamics recorded gross profit of 46.77 million USD in its latest quarterly report.

What was AngioDynamics’s annual operating income?

For the full year, AngioDynamics (ANGO) reported operating income of -22.47 million USD.

What was AngioDynamics’s operating income last quarter?

Quarterly operating income was -5.65 million USD.

What was AngioDynamics’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at -0.35 million USD.

What was the quarter-over-quarter change in EBITDA for AngioDynamics?

EBITDA changed by 57.88% million USD compared to the last quarter.

What is AngioDynamics’s most recent gross profit margin?

The latest reported gross profit margin for AngioDynamics (ANGO) is 54.01% million USD.

What is AngioDynamics’s most recent net income margin?

Net income margin based on recent financials is -13.17% million USD.

What is AngioDynamics’s most recent EBIT margin?

AngioDynamics reported an EBIT margin of -6.52% million USD based on current figures.

How did AngioDynamics’s revenue change compared to the previous quarter?

Revenue changed by 10.44% million USD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for AngioDynamics?

In the latest quarter, gross profit changed by 12.76% million USD from the previous quarter.

S&P/TSX

36,265.69

-136.10

-0.37%

S&P/TSX 60

2,126.65

-9.49

-0.44%

US 30

52,812.70

-650.4

-1.22%

US 500

7,653.30

-55.1

-0.71%

S&P 500 VIX

16.13

+1.24

+8.33%

DAX

26,011.55

-79.78

-0.31%

Dollar Index

98.823

+0.092

+0.09%

Market Movers

Name	Last	Chg. %	Vol.
Bank of Montreal	238.12	-1.85%	1.60M
Enbridge	70.53	+1.50%	5.37M
RBC	282.94	-1.39%	1.16M
Toronto Dominion Bank	160.88	-1.69%	1.83M
Canadian Natural	70.04	+2.28%	2.94M
Sun Life Financial	107.94	-1.80%	1.79M
Agnico Eagle Mines	289.28	+0.85%	634.17K

Name	Last	Chg. %	Vol.
Lanebury Growth Capital	0.15	+200.00%	1.00K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Avalon Advanced Materials	12.200	+106.43%	206.51K
Avalon Advanced Materials	11.800	+100.68%	14.15K
Digital Asset Tech	0.01	+100.00%	15.50K
Beckett’s	0.010	+100.00%	5.00K
ePlay Digital	0.010	+100.00%	7.00K

Name	Last	Chg. %	Vol.
Patriot Gold	0.01	-87.50%	1.00K
Nepra Foods	0.18	-50.68%	73.40K
Molecule Holdings	0.005	-50.00%	20.11K
Pharmadrug	0.0050	-50.00%	277.00K
Mcf Energy	0.02	-50.00%	745.00K
Blue Horizon Global Capital	0.005	-50.00%	145.10K
Albert Labs International	0.005	-50.00%	1.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Toronto Dominion Bank	160.88	-1.69%	1.83M
Celestica Inc.	413.00	-0.86%	128.44K
Keel Infra	4.48	+0.22%	2.69M
Bank of Montreal	238.12	-1.85%	1.60M
Canadian Imperial Bank	159.85	-1.89%	768.87K

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aa Aa Aaaa A A	33.89	+53.15%	51.90
Aa Aaa Aa Aaaaa	1.4800	+49.86%	2.2179
Aaaaaaa	126.08	+48.82%	187.63
A Aaaaaa	20.27	+46.35%	29.67
Aaaaaaaaaaaaaaa	102.71	+45.43%	149.37
Aaaaaaaaaa	17.21	+44.33%	24.84
A Aaaaa Aaa	9.46	+41.37%	13.37

Name	Last	Upside	Fair Value
Aa Aa Aaaa A A	33.89	+53.15%	51.90
Aa Aaa Aa Aaaaa	1.4800	+49.86%	2.2179
Aaaaaaa	126.08	+48.82%	187.63
A Aaaaaa	20.27	+46.35%	29.67
Aaaaaaaaaaaaaaa	102.71	+45.43%	149.37
Aaaaaaaaaa	17.21	+44.33%	24.84
A Aaaaa Aaa	9.46	+41.37%	13.37

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

AngioDynamics Inc (ANGO)

ANGO Income Statement

FAQ

What was AngioDynamics’s revenue at year end?

How much revenue did AngioDynamics report in the most recent quarter?

What was AngioDynamics’s net income for the year?

How much net income did AngioDynamics post in the last quarter?

What was AngioDynamics’s gross profit for the year?

How much gross profit did AngioDynamics generate last quarter?

What was AngioDynamics’s annual operating income?

What was AngioDynamics’s operating income last quarter?

What was AngioDynamics’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for AngioDynamics?

What is AngioDynamics’s most recent gross profit margin?

What is AngioDynamics’s most recent net income margin?

What is AngioDynamics’s most recent EBIT margin?

How did AngioDynamics’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for AngioDynamics?

Trending Stocks